Literature DB >> 3699824

Genetic polymorphism of human complement component C81 in the Japanese population.

S Nakamura, O Ohue, K Abe.   

Abstract

Genetic polymorphism of human C81 has been investigated using polyacrylamide gel isoelectric focusing (PAGIEF) in the presence of 3.1 M urea followed by electroblotting with enzyme immunoassay. In 448 individuals phenotypes of C81 were classified into three common and four rare patterns, and these were considered to be controlled by two common alleles, C81 A and C81 B, and three rare alleles which were tentatively designated C81 A1J and C81 A2J for acidic variants and C81 B1J for the basic variant. The alleles of C81 A2J and C81 B1J are new rare alleles, but C81 A1J might correspond to C81 A1 in the former studies. Family data were in accordance with the hereditary rules. The gene frequencies were estimated as C81 A is 0.6228, C81 B is 0.3672, C81 A1J is 0.0078, C81 A2J is 0.0011, and C81 B1J is 0.0011, respectively. The gene frequencies of the two common alleles agreed approximately with other ethnic groups. PAGIEF of neuraminidase-treated plasma samples followed by electroblotting with enzyme immunoassay is applicable to the study of heterogeneity of C81.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699824     DOI: 10.1007/bf00290962

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Genetic polymorphism of complement component C8.

Authors:  S Rogde; B Mevåg; P Teisberg; T Gedde-Dahl; F Tedesco; B Olaisen
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Genetic polymorphism of human factor I (C3b inactivator).

Authors:  S Nakamura; K Abe
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  Genetic polymorphism of the seventh component of complement in a Japanese population.

Authors:  S Nakamura; O Ooue; K Abe
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Population and formal genetics of the human C81(alpha-gamma) polymorphism.

Authors:  C Rittner; W Hargesheimer; E Mollenhauer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure.

Authors:  E W Steckel; R G York; J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

7.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

8.  Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).

Authors:  C A Alper; D Marcus; D Raum; B H Petersen; T J Spira
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Genetic control of the eighth component of complement.

Authors:  D Raum; M A Spence; D Balavitch; S Tideman; A D Merritt; R T Taggart; B H Petersen; N K Day; C A Alper
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  The membrane attack mechanism of complement: the three polypeptide chain structure of the eigth component (C8).

Authors:  W P Klob; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.